Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Guaraldi

Showing results (111-120 of 408) with videos related to

Pageof 41
Sort By:
HIV Medicine|February 24, 2022
"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV"Adriana Cervo, Giada Sebastiani, Jovana Milic, et al.
International Forum of Allergy & Rhinology|February 4, 2021
Patient-reported olfactory recovery after SARS-CoV-2 infection: A 6-month follow-up studyDaniela Lucidi, Giulia Molinari, Martina Silvestri, et al.
AIDS Research and Human Retroviruses|February 15, 2021
Re: "No Significant Changes in Weight and Body Fat Mass in Suppressed HIV Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir" by Calza <i>et al.</i>Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
Italian Journal of Dermatology and Venereology|July 20, 2021
HIV and syphilis: incidence rate of coinfection and syphilis reinfection in a cohort of newly diagnosed HIV patientsFrancesca DI Tullio, Victor D Mandel, Gianluca Cuomo, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2008
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational studyGiovanni Guaraldi, Alberto Roverato, Chiara Giovanardi, et al.
Infectious Disease Reports|September 11, 2020
Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infectionGianluca Cuomo, Marianna Menozzi, Federica Carli, et al.
Current HIV Research|March 30, 2011
Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID inductionRenato Maserati, Micaela Brandolini, Annamaria Cattelan, et al.
European Journal of Endocrinology|December 23, 2011
GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controlsLucia Zirilli, Gabriella Orlando, Federica Carli, et al.
Clinical Kidney Journal|February 24, 2023
Which criteria should we use to end isolation in hemodialysis patients with COVID-19?Gaetano Alfano, Francesco Fontana, Annachiara Ferrari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2010
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitorsGiovanni Guaraldi, Chiara Stentarelli, Gabriella Orlando, et al.
Pageof 41

Showing results (111-120 of 408) with videos related to

Sort By:
Pageof 41
HIV Medicine|February 24, 2022
"Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV"Adriana Cervo, Giada Sebastiani, Jovana Milic, et al.
International Forum of Allergy & Rhinology|February 4, 2021
Patient-reported olfactory recovery after SARS-CoV-2 infection: A 6-month follow-up studyDaniela Lucidi, Giulia Molinari, Martina Silvestri, et al.
AIDS Research and Human Retroviruses|February 15, 2021
Re: "No Significant Changes in Weight and Body Fat Mass in Suppressed HIV Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir" by Calza <i>et al.</i>Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
Italian Journal of Dermatology and Venereology|July 20, 2021
HIV and syphilis: incidence rate of coinfection and syphilis reinfection in a cohort of newly diagnosed HIV patientsFrancesca DI Tullio, Victor D Mandel, Gianluca Cuomo, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 2008
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational studyGiovanni Guaraldi, Alberto Roverato, Chiara Giovanardi, et al.
Infectious Disease Reports|September 11, 2020
Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infectionGianluca Cuomo, Marianna Menozzi, Federica Carli, et al.
Current HIV Research|March 30, 2011
Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID inductionRenato Maserati, Micaela Brandolini, Annamaria Cattelan, et al.
European Journal of Endocrinology|December 23, 2011
GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controlsLucia Zirilli, Gabriella Orlando, Federica Carli, et al.
Clinical Kidney Journal|February 24, 2023
Which criteria should we use to end isolation in hemodialysis patients with COVID-19?Gaetano Alfano, Francesco Fontana, Annachiara Ferrari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2010
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitorsGiovanni Guaraldi, Chiara Stentarelli, Gabriella Orlando, et al.
Pageof 41